成人B站猎奇版

Cardiac myosin inhibitor linked to improvements in biomarkers in small study

Vast majority of trial participants responded to aficamten

Benefit of the nonsteroidal MRA otherwise consistent across FINEARTS-HF

Meta-analysis holds LGE higher than LVEF in identifying high-risk NIDCM

Study lays out common gaps in evidence both before and after approval

Continued OAC failed to meet noninferiority in POPular PAUSE TAVI

Randomized trial shows benefits beyond heart failure with low ejection fraction, but not survival

NOTION-3 trial informs care for those with severe AS and stable CAD

RESHAPE-HF2 has provocative implications for a wider pool of TEER candidates

Randomized trial "highly encouraging" for making patients feel and function better

Either choice is "acceptable" based on randomized study

RNA silencer impresses with results in transthyretin amyloidosis cardiomyopathy

ACE-PROTAVI trial tested upfront vs selective use of heparin reversal agent

Report is part of larger efforts to increase awareness of neglected disease